The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...

Obesity alters how medications work, increasing the risk of underdosing, overdosing, and unknown interactions. Are package ...

A recent study shows that traditional insulin resistance measures such as HOMA-IR are more predictive of insulin resistance ...

In this video at Obesity Medicine 2025, Harold E. Bays, MD, FOMA, FTOS, FACC, FASPC, FNLA, discusses highlights from his talk ...

Fox News @ Night’ panelists Tom Kenney and Dr. Houman Hemmati discuss the defense secretary’s new initiative aimed at ...

Health360 focusses on India's obesity epidemic and Prime Minister Modi's recent call to tackle it. Experts discuss the rise ...

A comprehensive new review by researchers at the University of Kentucky sheds light on the intricate and damaging ...

For true pet parents, life revolves around keeping their furry friends happy and healthy. But if meals aren't portioned to ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Roche posted a Q1 revenue beat, with strong contributions from Phesgo, Xolair, and Polivy, despite larger products lagging.

In summary, this study shows that long-term patterns of obesity—especially sustained or increasing weight over time—can ...

Obesity and related metabolic disorders, such as hyperlipidemia and non-alcoholic fatty liver disease, have become ...